Roivant Sciences ROIV Ratios & Valuation
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| Efficiency | ||||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Liquidity | ||||||
| Current ratio | 123.3×+13.6× | 138.4×+36.9× | 145.6×+54.3× | 122.3×+35.6× | 109.7×+44.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×-0.1× | 0.1×-0.2× | 0.1×-0.7× | 0.1×-1.1× | |
| Per Share | ||||||
| Book value per share | $25.45-7.8% | $25.38-10.4% | $26.44-6.8% | $27.04+19.7% | $27.60+64.1% | |
| Valuation | ||||||
| Market capitalization | $53.09B+65.5% | $40.47B+21.4% | $33.99B+0.8% | $32.15B-6.1% | $32.08B-6.2% | |
| Price / sales | 4,379.9×+3,406× | 2,227.6×+1,332× | 1,376×+542× | 1,097×+280× | 974.1×+220× | |
| Price / book | 12.1×+5.8× | 9.2×+3.1× | 7.4×+1.4× | 6.6×-7.2× | 6.3×-14.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Roivant Sciences's ratios come from?
- Every ratio is computed from Roivant Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
